Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Oct 30, 2021 11:06am
80 Views
Post# 34067995

House Positions Last Week

House Positions Last Week
House Positions for C:ARCH from 20211025 to 20211029
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 98,000 269,837 2.753 9,000 24,780 2.753 89,000 -245,057
33 Canaccord 26,300 73,993 2.813 500 1,375 2.75 25,800 -72,618
85 Scotia 24,673 68,198 2.764 2,228 6,189 2.778 22,445 -62,009
9 BMO Nesbitt 34,325 95,510 2.783 25,700 72,285 2.813 8,625 -23,225
89 Raymond James 17,614 50,303 2.856 10,863 29,284 2.696 6,751 -21,019
14 ITG 4,522 12,292 2.718 354 983 2.777 4,168 -11,309
88 Credential 4,200 11,534 2.746 407 1,111 2.73 3,793 -10,423
80 National Bank 6,448 17,923 2.78 2,871 8,079 2.814 3,577 -9,844
53 Morgan Stanley 691 1,914 2.77 0   691 -1,914
68 Leede 1,525 4,206 2.758 847 2,359 2.785 678 -1,847
124 Questrade 7,394 20,555 2.78 6,783 18,901 2.787 611 -1,654
84 Ind Trading 74 199 2.689 50 138 2.76 24 -61
57 Interactive 0   100 279 2.79 -100 279
13 Instinet 100 278 2.78 1,000 2,750 2.75 -900 2,472
74 GMP 0   2,200 6,133 2.788 -2,200 6,133
2 RBC 6,600 18,269 2.768 11,316 31,282 2.764 -4,716 13,013
79 CIBC 33,164 92,468 2.788 40,527 113,595 2.803 -7,363 21,127
7 TD Sec 19,414 53,821 2.772 53,871 145,340 2.698 -34,457 91,519
1 Anonymous 124,467 342,504 2.752 240,894 668,946 2.777 -116,427 326,442
TOTAL 409,511 1,133,804 2.769 409,511 1,133,809 2.769 0 5

<< Previous
Bullboard Posts
Next >>